Absci

Organization

Heard in 2 episodes across 2 shows since Jun 2026

Absci is a clinical-stage biopharmaceutical company that utilizes generative artificial intelligence to design and advance innovative therapeutics. The company's Integrated Drug Creation platform combines deep learning models with high-throughput biological validation to discover and optimize biologics against difficult-to-drug targets.

Episodes

across 2 shows

First heard

Jun 2026

Expert statements

1 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data

Month	Episodes
Nov 2025	0
Dec 2025	0
Jan 2026	0
Feb 2026	0
Mar 2026	0
Apr 2026	0
May 2026	0
Jun 2026	1
Jul 2026	0
Aug 2026	0
Sep 2026	1
Oct 2026	0

What experts have said about Absci

1 statement · 1 positive

Avalon PurnellPositiveJun 24, 2026· Stock Movers
Absci stock rose about 38%, reaching its highest intraday level since 2021.
“Currently up about 38% to hit its highest intraday level since 2021.”
Listen at 3:26
Open the episode · Wendy's Soars, Hertz Tumbles, Absci Surges

Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

2 episodes featuring Absci, newest first